Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers for response to rapamycin analogs

Biomarkers for response to rapamycin analogs

US Patent 10610521 · Granted Apr 7, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds useful for the treatment of infection with Mannheimia haemolytica or H2025
Compounds for the treatment of bovine or swine respiratory disease2024
Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infe2024
Compositions and methods for the diagnosis and treatment of ovarian cancers that2022
Compounds for the treatment of bovine or swine respiratory disease2022
Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of pr2021
Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of pr2021
Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infe2021
Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of pr2021
Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of pr2021
Process for preparing substituted crotonic acids2020
Heteroaryl compounds with A-cyclic bridging unit2016